Ascension Asset Management LLC Abb Vie Inc. Transaction History

Ascension Asset Management LLC

$192 Million
Q2 2024

A detailed history of Ascension Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ascension Asset Management LLC holds 9,362 shares of ABBV stock, worth $1.88 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

9,362

Previous 10,012 6.49%

Holding current value

$1.88 Million

Previous $1.82 Million 11.96%

% of portfolio

0.84%

Previous 1.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$154.79 - $180.76 $100,613 - $117,494	-650 Reduced 6.49%	9,362 $1.61 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $79,910 - $91,050	-500 Reduced 4.76%	10,012 $1.82 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $25,872 - $32,892	-188 Reduced 1.76%	10,512 $1.61 Million
Q4 2021 Feb 15, 2022	SELL	$107.43 - $135.93 $32,229 - $40,779	-300 Reduced 2.73%	10,700 $1.45 Million
Q3 2021 Nov 18, 2021	SELL	$106.4 - $120.78 $5,320 - $6,039	-50 Reduced 0.45%	11,000 $1.19 Million
Q2 2021 Jul 29, 2021	SELL	$105.21 - $117.21 $41,452 - $46,180	-394 Reduced 3.44%	11,050 $1.25 Million
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $1.17 Million - $1.29 Million	11,444 New	11,444 $1.21 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $931,188 - $1.26 Million	-11,569 Closed	0 $0
Q3 2020 Oct 19, 2020	BUY	$85.91 - $100.83 $4,295 - $5,041	50 Added 0.43%	11,569 $1.01 Million
Q1 2020 Aug 19, 2020	SELL	$64.5 - $97.79 $12,255 - $18,580	-190 Reduced 1.62%	11,519 $878,000
Q4 2019 Jan 15, 2020	SELL	$72.13 - $90.25 $10,819 - $13,537	-150 Reduced 1.26%	11,709 $1.04 Million
Q3 2019 Oct 22, 2019	SELL	$62.98 - $75.72 $72,427 - $87,078	-1,150 Reduced 8.84%	11,859 $898,000
Q2 2019 Jul 23, 2019	SELL	$65.7 - $83.98 $25,951 - $33,172	-395 Reduced 2.95%	13,009 $946,000
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $17,356 - $20,427	-225 Reduced 1.65%	13,404 $1.08 Million
Q3 2018 Oct 30, 2018	SELL	$88.91 - $98.84 $27,562 - $30,640	-310 Reduced 2.22%	13,629 $1.29 Million
Q2 2018 Aug 08, 2018	BUY	$89.78 - $106.23 $55,663 - $65,862	620 Added 4.66%	13,939 $1.29 Million
Q4 2017 Jan 24, 2018	BUY	$89.56 - $98.21 $1.19 Million - $1.31 Million	13,319	13,319 $1.29 Million

Others Institutions Holding ABBV

# of Institutions

3,783

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $356B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascension Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascension Asset Management LLC with notifications on news.

Account

Ascension Asset Management LLC Abb Vie Inc. Transaction History